Artelo Biosciences Inc ARTL:NASDAQ

Last Price$0.39NASDAQ Closing Price as of 4:00PM ET 1/28/22

Today's Change+0.02(5.46%)
Bid (Size)$0.38 (16)
Ask (Size)$0.39 (2)
Day Low / High$0.36 - 0.40
Volume670.9 K

View Catalog/Specialty Distribution IndustryPeer Comparison as of 01/28/2022


Artelo Biosciences Inc ( NASDAQ )

Price: $0.39
Change: +0.02 (5.46%)
Volume: 670.9 K
4:00PM ET 1/28/2022

Strategic Management & Opportunity Corp ( OTC )

Price: $0.02
Change: 0.00 (0.00%)
Volume: 17.1 K
3:53PM ET 12/09/2021

Pazoo Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 2.0 K
1:09PM ET 1/10/2022

Shengshi International Holding Group Inc ( OTC )

Price: $0.02
Change: 0.00 (0.00%)
Volume: 10.0 K
9:15AM ET 9/27/2021

APT Moto Vox Group Inc ( OTC )

Price: $0.00
Change: 0.00 (0.00%)
Volume: 1.0 K
9:32AM ET 1/06/2022

Read more news Recent News

Artelo Biosciences' Lead Cannabinoid No Longer Schedule 1 Controlled Substance in UK; Shares Rise Pre-Bell
9:30AM ET 1/11/2022 MT Newswires

Artelo Biosciences (ARTL) reported that the UK government no longer considers the company's lead clinical cannabinoid ART27.13 a Schedule 1 controlled...

Top Premarket Gainers
8:08AM ET 11/04/2021 MT Newswires

Evaxion Biotech (EVAX) shares more than doubled following a 10.8% loss in the previous session, up 235%. TDH Holdings (PETZ) shares soared more than 63%...

Top Midday Gainers
1:16PM ET 11/01/2021 MT Newswires

ABVC Biopharma (ABVC) said late Friday it filed a registration statement for a proposed offering of up to $50 million of its securities, but did not...

Top Premarket Gainers
8:53AM ET 11/01/2021 MT Newswires

ABVC Biopharma (ABVC) shares more than tripled in value. The company filed a registration statement for the offering of up to $50 million worth of...

Company Profile

Business DescriptionArtelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded by James Manley on May 2, 2011 and is headquartered in Solana Beach, CA. View company web site for more details
Address505 Lomas Santa Fe
Solana Beach, California 92075
Number of Employees2
Recent SEC Filing01/12/202210-Q
President, CEO, CFO, Secretary & TreasurerGregory D. Gorgas
Vice President-Finance & OperationsRandy Schreckhise
Chief Medical OfficerSteven D. Reich
Chief Scientific Officer & Senior Vice PresidentAndy Yates

Company Highlights

Price Open$0.37
Previous Close$0.37
52 Week Range$0.35 - 3.67
Market Capitalization$16.5 M
Shares Outstanding42.3 M
SectorRetail Trade
IndustryCatalog/Specialty Distribution
Next Earnings Announcement04/12/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.37
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-52.54%

Analyst Ratings as of 01/15/2022

Consensus RecommendationConsensus Icon
Powered by Factset